Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists' Collaboration.
Collins
R
R
ICRF/BHF/MRC Clinical Trial Service Unit, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford.
Baigent
C
C
Sandercock
P
P
Peto
R
R
D016063:Blood Loss, Surgical; D003625:Data Collection; D003627:Data Interpretation, Statistical; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D013923:Thromboembolism / Q000517:prevention & control*; D013924:Thrombophlebitis / Q000517:prevention & control; D016896:Treatment Outcome
D010975:Platelet Aggregation Inhibitors; D006493:Heparin